These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36864014)

  • 41. Insulin Pump Combined with Flash Glucose Monitoring: A Therapeutic Option to Improve Glycemic Control in Severely Nonadherent Patients with Type 1 Diabetes.
    Halbron M; Bourron O; Andreelli F; Ciangura C; Jacqueminet S; Popelier M; Bosquet F; Rouanet S; Amouyal C; Hartemann A
    Diabetes Technol Ther; 2019 Jul; 21(7):409-412. PubMed ID: 31265349
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Combined continuous glucose monitoring and subcutaneous insulin infusion versus self-monitoring of blood glucose with optimized multiple injections in people with type 1 diabetes: A randomized crossover trial.
    Dicembrini I; Pala L; Caliri M; Minardi S; Cosentino C; Monami M; Mannucci E
    Diabetes Obes Metab; 2020 Aug; 22(8):1286-1291. PubMed ID: 32166907
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial.
    Messer LH; Buckingham BA; Cogen F; Daniels M; Forlenza G; Jafri RZ; Mauras N; Muir A; Wadwa RP; White PC; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro CA; Li Z; Marak MC; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 Oct; 24(10):712-725. PubMed ID: 36173237
    [No Abstract]   [Full Text] [Related]  

  • 44. Glycaemia in low-premixed insulin analogue type 2 diabetes patients in a real-world setting: are the CGM targets met?
    Krajnc M; Kravos Tramšek NA
    Eur J Med Res; 2023 Mar; 28(1):111. PubMed ID: 36882852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. REPLACE-BG: A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Well-Controlled Type 1 Diabetes.
    Aleppo G; Ruedy KJ; Riddlesworth TD; Kruger DF; Peters AL; Hirsch I; Bergenstal RM; Toschi E; Ahmann AJ; Shah VN; Rickels MR; Bode BW; Philis-Tsimikas A; Pop-Busui R; Rodriguez H; Eyth E; Bhargava A; Kollman C; Beck RW;
    Diabetes Care; 2017 Apr; 40(4):538-545. PubMed ID: 28209654
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA
    Thabit H; Prabhu JN; Mubita W; Fullwood C; Azmi S; Urwin A; Doughty I; Leelarathna L
    Diabetes Care; 2020 Oct; 43(10):2537-2543. PubMed ID: 32723843
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Associations of Mean Glucose and Time in Range from Continuous Glucose Monitoring with HbA1c in Adults with Type 2 Diabetes.
    Selvin E; Wang D; Rooney MR; Echouffo-Tcheugui J; Fang M; Zeger S; Sartini J; Tang O; Coresh J; Aurora RN; Punjabi NM
    Diabetes Technol Ther; 2023 Jan; 25(1):86-90. PubMed ID: 36108310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relationships between HbA1c and continuous glucose monitoring metrics of glycaemic control and glucose variability in a large cohort of children and adolescents with type 1 diabetes.
    Piona C; Marigliano M; Mozzillo E; Rosanio F; Zanfardino A; Iafusco D; Maltoni G; Zucchini S; Piccinno E; Delvecchio M; Maffeis C
    Diabetes Res Clin Pract; 2021 Jul; 177():108933. PubMed ID: 34216681
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effectiveness of Continuous Glucose Monitoring in Older Adults with Type 2 Diabetes Treated with Basal Insulin.
    Bao S; Bailey R; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 May; 24(5):299-306. PubMed ID: 34939824
    [No Abstract]   [Full Text] [Related]  

  • 50. Continuous Glucose Monitoring-Recorded Hypoglycemia with Insulin Degludec or Insulin Glargine U100 in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia.
    Brøsen JMB; Agesen RM; Alibegovic AC; Ullits Andersen H; Beck-Nielsen H; Gustenhoff P; Krarup Hansen T; Hedetoft CGR; Jensen TJ; Stolberg CR; Bogh Juhl C; Lerche SS; Nørgaard K; Parving HH; Tarnow L; Thorsteinsson B; Pedersen-Bjergaard U
    Diabetes Technol Ther; 2022 Sep; 24(9):643-654. PubMed ID: 35467938
    [No Abstract]   [Full Text] [Related]  

  • 51. Early Initiation of Diabetes Devices Relates to Improved Glycemic Control in Children with Recent-Onset Type 1 Diabetes Mellitus.
    Patton SR; Noser AE; Youngkin EM; Majidi S; Clements MA
    Diabetes Technol Ther; 2019 Jul; 21(7):379-384. PubMed ID: 31166808
    [No Abstract]   [Full Text] [Related]  

  • 52. Real-time continuous glucose monitoring improves glycemic control and reduces hypoglycemia: Real-world data.
    Kant R; Antony MA; Geurkink D; Gilreath N; Chandra L; Zipprer E; Munir KM; Chandra R; Parker VG; Verma V
    Prim Care Diabetes; 2022 Dec; 16(6):786-790. PubMed ID: 36117090
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical use of a 180-day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes.
    Irace C; Cutruzzolà A; Nuzzi A; Assaloni R; Brunato B; Pitocco D; Tartaglione L; Di Molfetta S; Cignarelli A; Laviola L; Citro G; Lovati E; Gnasso A; Tweden KS; Kaufman FR
    Diabetes Obes Metab; 2020 Jul; 22(7):1056-1061. PubMed ID: 32037699
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance of the Dexcom G6 Continuous Glucose Monitoring System in Pregnant Women with Diabetes.
    Castorino K; Polsky S; O'Malley G; Levister C; Nelson K; Farfan C; Brackett S; Puhr S; Levy CJ
    Diabetes Technol Ther; 2020 Dec; 22(12):943-947. PubMed ID: 32324061
    [No Abstract]   [Full Text] [Related]  

  • 55. Continuous glucose monitoring systems in well-controlled children with type 1 diabetes mellitus.
    M Kowalczyk E; Adamczyk M; Pietrzyk J; Jastrzębska B; Szypowska A
    Pediatr Endocrinol Diabetes Metab; 2021; 27(3):151-158. PubMed ID: 34596369
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Optimization of insulin regimen and glucose outcomes with short-term real-time continuous glucose monitoring (RT-CGM) in type 1 diabetic children with sub-optimal glucose control on multiple daily injections: The pediatric DIACCOR study.
    Picard S; Bonnemaison-Gilbert E; Leutenegger E; Barat P
    Arch Pediatr; 2019 Feb; 26(2):95-101. PubMed ID: 30642746
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is there a difference in pregnancy and glycemic outcome in patients with type 1 diabetes on insulin pump with constant or intermittent glucose monitoring? A pilot study.
    Petrovski G; Dimitrovski C; Bogoev M; Milenkovic T; Ahmeti I; Bitovska I
    Diabetes Technol Ther; 2011 Nov; 13(11):1109-13. PubMed ID: 21751889
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Randomised controlled trial of Advanced Hybrid Closed Loop in an Adult Population with Type 1 Diabetes (ADAPT): study protocol and rationale.
    de Portu S; Vorrink L; Re R; Shin J; Castaneda J; Habteab A; Cohen O
    BMJ Open; 2022 Feb; 12(2):e050635. PubMed ID: 35110310
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial.
    Bosi E; Choudhary P; de Valk HW; Lablanche S; Castañeda J; de Portu S; Da Silva J; Ré R; Vorrink-de Groot L; Shin J; Kaufman FR; Cohen O;
    Lancet Diabetes Endocrinol; 2019 Jun; 7(6):462-472. PubMed ID: 31047902
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reliability of Inpatient CGM: Comparison to Standard of Care.
    Price C; Ditton G; Russell GB; Aloi J
    J Diabetes Sci Technol; 2023 Mar; 17(2):329-335. PubMed ID: 34911384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.